Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
Y. Guo, A. Kawaguchi, M. Takeshita, T. Sekiya, M. Hirohama, A. Yamashita, the Keio Donner Project, H. Siomi, K. Murano
This study develops mouse monoclonal antibodies against SARS-CoV-2 spike protein that show neutralizing activity and are suitable for immunoassays and large-scale production.
bioRxiv · Oct 1, 2020Microbiology